Search - tctmd.com

Displaying 181 - 200 of 1423

Sort: Relevancy | Date

Presentation TCT 2017

Case Examples of Interventionalists Social Medial Platforms III

Presenter: C. Michael Gibson, Shelley Wood, Sunil V. Rao

November 01, 2017

Presentation TCT 2017

When Is Medical Therapy the Best Choice in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung

November 01, 2017

Presentation TCT 2017

Impact of DCB Technique on Long-term Vessel Patency: Can Clinical Outcomes Be Optimized?

Presenter: William A. Gray, Thomas Zeller

November 01, 2017

Presentation TCT 2017

Case Examples of Interventionalists Social Medial Platforms II

Presenter: C. Michael Gibson, Shelley Wood

November 01, 2017

Presentation TCT 2017

Starting a Clinical Interventional Practice: Real-world Lessons

Presenter: Michael J. Rinaldi, David O. Williams, Ethan C Korngold

November 01, 2017

Presentation TCT 2017

Case Examples of Interventionalists Social Medial Platforms I

Presenter: C. Michael Gibson, Shelley Wood, Mirvat Alasnag

November 01, 2017

Presentation TCT 2017

Is There a Preferred Stent for the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Upendra Kaul

November 01, 2017

Presentation TCT 2017

Long-term Data With Lower-Dose DCB Technologies (LEVANT, ILLUMINATE, RANGER)

Presenter: William A. Gray, Thomas Zeller, Mitchell Weinberg

November 01, 2017

Presentation TCT 2017

When Should PCI Be Preferred in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Sripal Bangalore

November 01, 2017

Presentation TCT 2017

Long-Term Data With Standard-Dose DCB Technologies (IN.PACT SFA and the Consequent Trial)

Presenter: William A. Gray, Thomas Zeller, Peter A. Schneider

November 01, 2017

Presentation TCT 2017

Twitter, Facebook, and Instagram 101: The Basics

Presenter: C. Michael Gibson, Shelley Wood, Sheila Sahni

November 01, 2017

Presentation TCT 2017

When Should CABG Be Preferred in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Jack Boyd

November 01, 2017

Presentation TCT 2017

Worldwide Deaths and MI From Coronary Atherosclerosis: Scope of an Epidemic

Presenter: John A. Ambrose, Y. S. Chandrashekhar, James E. Muller

November 01, 2017

Presentation TCT 2017

DCB Architecture: Technical Features Determining Long-term Safety and Efficacy

Presenter: William A. Gray, Thomas Zeller, Juan F. Granada

November 01, 2017

Presentation TCT 2017

REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS

Presenter: Robert A. Harrington, Gregg W. Stone, Harry Suryapranata

November 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

Presentation TCT 2017

Multimodality Imaging to Risk Stratify Patients With Aortic Stenosis

Presenter: Bernard Prendergast, Brian K. Whisenant, Victoria Delgado

November 01, 2017

Presentation TCT 2017

Asymptomatic Severe Aortic Stenosis: To Treat or to Watch?

Presenter: Bernard Prendergast, Brian K. Whisenant, Allan Schwartz

November 01, 2017

Presentation TCT 2017

DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI

Presenter: Robert A. Harrington, Gregg W. Stone, Elvin Kedhi

November 01, 2017

Presentation TCT 2017

Identifying the Futile Severe AS Patient - Who Shouldnt Be Treated With TAVR?

Presenter: Bernard Prendergast, Brian K. Whisenant, David J. Cohen

November 01, 2017

Advertisement

Case Examples of Interventionalists Social Medial Platforms III

When Is Medical Therapy the Best Choice in the Diabetic Patient?

Impact of DCB Technique on Long-term Vessel Patency: Can Clinical Outcomes Be Optimized?

Case Examples of Interventionalists Social Medial Platforms II

Starting a Clinical Interventional Practice: Real-world Lessons

Case Examples of Interventionalists Social Medial Platforms I

Is There a Preferred Stent for the Diabetic Patient?

Long-term Data With Lower-Dose DCB Technologies (LEVANT, ILLUMINATE, RANGER)

When Should PCI Be Preferred in the Diabetic Patient?

Long-Term Data With Standard-Dose DCB Technologies (IN.PACT SFA and the Consequent Trial)

Twitter, Facebook, and Instagram 101: The Basics

When Should CABG Be Preferred in the Diabetic Patient?

Worldwide Deaths and MI From Coronary Atherosclerosis: Scope of an Epidemic

DCB Architecture: Technical Features Determining Long-term Safety and Efficacy

REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS

Live From Denver: TCT 2017, Day Three

Multimodality Imaging to Risk Stratify Patients With Aortic Stenosis

Asymptomatic Severe Aortic Stenosis: To Treat or to Watch?

DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI

Identifying the Futile Severe AS Patient - Who Shouldnt Be Treated With TAVR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content